Dianthus Therapeutics | MGTA - Bénéfice Avant Impôts

Prix De L'Action
89.78
Variation Quotidienne
-1.88 -2.05%
Mensuellement
4.59%
Annuel
409.82%
Q2 Prévisions
83.41




Bénéfice Avant Impôts Changement Date
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
IQVIA Holdings USD 6.16B 5.84B 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -187M 631M 2025-09
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Organon & Co USD 243M 14M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 134.73M 7.91M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Sartorius EUR 85M 14.1M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -7.9M 209.2M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06